Jin Medical International Ltd. (ZJYL)
USD 0.83
(1.11%)
USD 0.83
(1.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 32.9 Million USD | 57.14% |
| 2022 | 20.93 Million USD | -4.39% |
| 2021 | 21.9 Million USD | 5.22% |
| 2020 | 20.81 Million USD | 2.23% |
| 2019 | 20.36 Million USD | 9.01% |
| 2018 | 18.67 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 41.16 Million USD | 25.09% |
| 2024 Q2 | 41.16 Million USD | 0.0% |
| 2023 Q4 | 32.9 Million USD | 0.0% |
| 2023 Q2 | 31.02 Million USD | 0.0% |
| 2023 Q3 | 32.9 Million USD | 6.06% |
| 2023 FY | 32.9 Million USD | 57.14% |
| 2023 Q1 | 31.02 Million USD | 48.15% |
| 2022 Q2 | 21.84 Million USD | 0.0% |
| 2022 FY | 20.93 Million USD | -4.39% |
| 2022 Q4 | 20.93 Million USD | 0.0% |
| 2022 Q3 | 20.93 Million USD | -4.14% |
| 2022 Q1 | 21.84 Million USD | -0.26% |
| 2021 Q2 | 24.25 Million USD | 0.0% |
| 2021 FY | 21.9 Million USD | 5.22% |
| 2021 Q3 | 21.9 Million USD | -9.69% |
| 2021 Q1 | 24.25 Million USD | 16.51% |
| 2021 Q4 | 21.9 Million USD | 0.0% |
| 2020 Q2 | 22.18 Million USD | 0.0% |
| 2020 Q1 | 22.18 Million USD | 8.96% |
| 2020 FY | 20.81 Million USD | 2.23% |
| 2020 Q4 | 20.81 Million USD | 0.0% |
| 2020 Q3 | 20.81 Million USD | -6.18% |
| 2019 Q4 | 20.36 Million USD | 0.0% |
| 2019 Q3 | 20.36 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 20.36 Million USD | 9.01% |
| 2018 FY | 18.67 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 81.758% |
| AngioDynamics, Inc. | 317.67 Million USD | 89.642% |
| AtriCure, Inc. | 613.93 Million USD | 94.641% |
| Avinger, Inc. | 13.77 Million USD | -138.95% |
| Azenta, Inc. | 2.88 Billion USD | 98.86% |
| BioLife Solutions, Inc. | 412.71 Million USD | 92.028% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.718% |
| Daxor Corporation | 34.86 Million USD | 5.637% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -13.782% |
| Femasys Inc. | 27.75 Million USD | -18.546% |
| GlucoTrack, Inc. | 4.9 Million USD | -570.814% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 76.047% |
| Hologic, Inc. | 9.15 Billion USD | 99.641% |
| ICU Medical, Inc. | 4.37 Billion USD | 99.249% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.787% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -15.609% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 90.512% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -429.1% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -429.1% |
| Masimo Corporation | 3.04 Billion USD | 98.918% |
| Microbot Medical Inc. | 8.32 Million USD | -295.142% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 80.861% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 98.585% |
| Nephros, Inc. | 11.86 Million USD | -177.409% |
| NovoCure Limited | 1.14 Billion USD | 97.129% |
| NEXGEL, Inc. | 9.95 Million USD | -230.522% |
| NEXGEL, Inc. | 9.95 Million USD | -230.522% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 87.605% |
| OraSure Technologies, Inc. | 482.84 Million USD | 93.186% |
| Pro-Dex, Inc. | 54.21 Million USD | 39.304% |
| Pulse Biosciences, Inc. | 60.8 Million USD | 45.886% |
| Predictive Oncology Inc. | 14.41 Million USD | -128.223% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -94.55% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.616% |
| Repligen Corporation | 2.82 Billion USD | 98.835% |
| Sanara MedTech Inc. | 73.87 Million USD | 55.458% |
| STAAR Surgical Company | 488.69 Million USD | 93.267% |
| Sharps Technology, Inc. | 11.78 Million USD | -179.097% |
| Utah Medical Products, Inc. | 135.45 Million USD | 75.709% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.554% |